Đang chuẩn bị liên kết để tải về tài liệu:
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Ovarian cancer (OC) is extremely heterogeneous and most cases are advanced stages at diagnosis. OC has a high response rate initially, but becomes resistant to standard chemotherapy. We previously employed high throughput global shRNA sensitization screens to identify NF-kB related pathways. |